|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0033325,
umls-concept:C0038952,
umls-concept:C0085862,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0279702,
umls-concept:C1299583,
umls-concept:C1413052,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C2698872
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-2-10
|
|
pubmed:abstractText |
Metastatic renal cell carcinoma (RCC) has a poor prognosis and an unpredictable course. To date, there are no molecular markers which can reliably predict RCC outcome. We investigated whether a novel kidney cancer marker, carbonic anhydrase IX (CAIX), is associated with progression and survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BelldegrunArie SAS,
pubmed-author:BuiMatthew H TMH,
pubmed-author:ChopraShefaliS,
pubmed-author:DoreyFrederick JFJ,
pubmed-author:FiglinRobert ARA,
pubmed-author:HanKen-ryuKR,
pubmed-author:HorvathSteveS,
pubmed-author:HuangYundaY,
pubmed-author:LeibovichBradley CBC,
pubmed-author:LermanMichael IMI,
pubmed-author:LiaoShu-YuanSY,
pubmed-author:PalotieAarnoA,
pubmed-author:PantuckAllan JAJ,
pubmed-author:SeligsonDavidD,
pubmed-author:StanbridgeEricE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
802-11
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12576453-Adenocarcinoma, Clear Cell,
pubmed-meshheading:12576453-Adult,
pubmed-meshheading:12576453-Aged,
pubmed-meshheading:12576453-Aged, 80 and over,
pubmed-meshheading:12576453-Antigens, Neoplasm,
pubmed-meshheading:12576453-Carbonic Anhydrases,
pubmed-meshheading:12576453-Carcinoma, Renal Cell,
pubmed-meshheading:12576453-Cohort Studies,
pubmed-meshheading:12576453-Female,
pubmed-meshheading:12576453-Humans,
pubmed-meshheading:12576453-Kidney Neoplasms,
pubmed-meshheading:12576453-Lymphatic Metastasis,
pubmed-meshheading:12576453-Male,
pubmed-meshheading:12576453-Middle Aged,
pubmed-meshheading:12576453-Neoplasm Proteins,
pubmed-meshheading:12576453-Neoplasm Staging,
pubmed-meshheading:12576453-Nephrectomy,
pubmed-meshheading:12576453-Predictive Value of Tests,
pubmed-meshheading:12576453-Prognosis,
pubmed-meshheading:12576453-Retrospective Studies,
pubmed-meshheading:12576453-Survival Analysis,
pubmed-meshheading:12576453-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
|
|
pubmed:affiliation |
Department of Urology, University of California, Los Angeles, California 90095-1738, USA.
|
|
pubmed:publicationType |
Journal Article
|
